HomeCompareRCM vs BTI

RCM vs BTI: Dividend Comparison 2026

RCM yields 13.98% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RCM wins by $12.4K in total portfolio value
10 years
RCM
RCM
● Live price
13.98%
Share price
$14.31
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50.1K
Annual income
$3,323.55
Full RCM calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — RCM vs BTI

📍 RCM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCMBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCM + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCM pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCM
Annual income on $10K today (after 15% tax)
$1,187.98/yr
After 10yr DRIP, annual income (after tax)
$2,825.02/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, RCM beats the other by $456.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCM + BTI for your $10,000?

RCM: 50%BTI: 50%
100% BTI50/50100% RCM
Portfolio after 10yr
$43.9K
Annual income
$3,055.09/yr
Blended yield
6.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RCM right now

RCM
Analyst Ratings
13
Buy
9
Hold
Consensus: Buy
Price Target
$17.11
+19.6% upside vs current
Range: $14.00 — $25.00
Altman Z
1.7
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCM buys
0
BTI buys
0
No recent congressional trades found for RCM or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCMBTI
Forward yield13.98%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$50.1K$37.7K
Annual income after 10y$3,323.55$2,786.64
Total dividends collected$23.2K$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy
Analyst price target$17.11$40.00

Year-by-year: RCM vs BTI ($10,000, DRIP)

YearRCM PortfolioRCM Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$12,098$1,397.62$11,299$598.92+$799.00RCM
2$14,525$1,580.18$12,794$703.91+$1.7KRCM
3$17,314$1,773.08$14,518$829.07+$2.8KRCM
4$20,502$1,975.37$16,513$978.64+$4.0KRCM
5$24,123$2,185.99$18,827$1,157.84+$5.3KRCM
6$28,215$2,403.82$21,518$1,373.12+$6.7KRCM
7$32,818$2,627.68$24,657$1,632.46+$8.2KRCM
8$37,972$2,856.39$28,329$1,945.74+$9.6KRCM
9$43,719$3,088.74$32,637$2,325.33+$11.1KRCM
10$50,102$3,323.55$37,708$2,786.64+$12.4KRCM

RCM vs BTI: Complete Analysis 2026

RCMStock

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.

Full RCM Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this RCM vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCM vs SCHDRCM vs JEPIRCM vs ORCM vs KORCM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.